We are live on ! Find out more
MHUA

Meihua International Medical Technologies

Delisted

MHUA was delisted on the 8th of December, 2025.

4 hedge funds and large institutions have $278K invested in Meihua International Medical Technologies in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

292% more capital invested

Capital invested by funds: $71K → $278K (+$207K)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

100% more funds holding

Funds holding: 24 (+2)

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$250K
2
JP Morgan Chase
JP Morgan Chase
New York
+$10.1K
3
UBS Group
UBS Group
Switzerland
+$8.41K
4
Citigroup
Citigroup
New York
+$1.68K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$62K
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
1
Invesco
Georgia
$246K +$250K +297 New
UBS Group
2
UBS Group
Switzerland
$20.6K +$8.41K +10 +67%
JP Morgan Chase
3
JP Morgan Chase
New York
$10K +$10.1K +12 New
Citigroup
4
Citigroup
New York
$1.76K +$1.68K +2 New
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
-$62K -109 Closed

MHUA Hedge Fund Activity: Q4 2022 in Review

4 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q4 2022, worth a combined $278K — up 292% from $71K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new MHUA positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Invesco, opening a new position worth an estimated $250K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $62K sold.

  • 4 institutional investors held Meihua International Medical Technologies (MHUA) as of Q4 2022, up from 2 in Q3 2022.
  • Funds reported $278K of Meihua International Medical Technologies stock for Q4 2022, up 292% quarter-over-quarter.
  • 3 funds opened new Meihua International Medical Technologies positions in Q4 2022 and 1 closed out, a net change of +2 holders.
  • The largest Meihua International Medical Technologies buyer in Q4 2022 was Invesco, an estimated $250K added.
  • The largest Meihua International Medical Technologies seller in Q4 2022 was Susquehanna International Group, an estimated $62K sold.

Based on aggregated 13F filings for Q4 2022.